BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 30586737)

  • 1. Genome-Wide Association Transethnic Meta-Analyses Identifies Novel Associations Regulating Coagulation Factor VIII and von Willebrand Factor Plasma Levels.
    Sabater-Lleal M; Huffman JE; de Vries PS; Marten J; Mastrangelo MA; Song C; Pankratz N; Ward-Caviness CK; Yanek LR; Trompet S; Delgado GE; Guo X; Bartz TM; Martinez-Perez A; Germain M; de Haan HG; Ozel AB; Polasek O; Smith AV; Eicher JD; Reiner AP; Tang W; Davies NM; Stott DJ; Rotter JI; Tofler GH; Boerwinkle E; de Maat MPM; Kleber ME; Welsh P; Brody JA; Chen MH; Vaidya D; Soria JM; Suchon P; van Hylckama Vlieg A; Desch KC; Kolcic I; Joshi PK; Launer LJ; Harris TB; Campbell H; Rudan I; Becker DM; Li JZ; Rivadeneira F; Uitterlinden AG; Hofman A; Franco OH; Cushman M; Psaty BM; Morange PE; McKnight B; Chong MR; Fernandez-Cadenas I; Rosand J; Lindgren A; ; Gudnason V; Wilson JF; Hayward C; Ginsburg D; Fornage M; Rosendaal FR; Souto JC; Becker LC; Jenny NS; März W; Jukema JW; Dehghan A; Trégouët DA; Morrison AC; Johnson AD; O'Donnell CJ; Strachan DP; Lowenstein CJ; Smith NL
    Circulation; 2019 Jan; 139(5):620-635. PubMed ID: 30586737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High levels of coagulation factors and venous thrombosis risk: strongest association for factor VIII and von Willebrand factor.
    Rietveld IM; Lijfering WM; le Cessie S; Bos MHA; Rosendaal FR; Reitsma PH; Cannegieter SC
    J Thromb Haemost; 2019 Jan; 17(1):99-109. PubMed ID: 30471183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genetic association study of circulating coagulation factor VIII and von Willebrand factor levels.
    de Vries PS; Reventun P; Brown MR; Heath AS; Huffman JE; Le NQ; Bebo A; Brody JA; Temprano-Sagrera G; Raffield LM; Ozel AB; Thibord F; Jain D; Lewis JP; Rodriguez BAT; Pankratz N; Taylor KD; Polasek O; Chen MH; Yanek LR; Carrasquilla GD; Marioni RE; Kleber ME; Trégouët DA; Yao J; Li-Gao R; Joshi PK; Trompet S; Martinez-Perez A; Ghanbari M; Howard TE; Reiner AP; Arvanitis M; Ryan KA; Bartz TM; Rudan I; Faraday N; Linneberg A; Ekunwe L; Davies G; Delgado GE; Suchon P; Guo X; Rosendaal FR; Klaric L; Noordam R; van Rooij F; Curran JE; Wheeler MM; Osburn WO; O'Connell JR; Boerwinkle E; Beswick A; Psaty BM; Kolcic I; Souto JC; Becker LC; Hansen T; Doyle MF; Harris SE; Moissl AP; Deleuze JF; Rich SS; van Hylckama Vlieg A; Campbell H; Stott DJ; Soria JM; de Maat MPM; Almasy L; Brody LC; Auer PL; Mitchell BD; Ben-Shlomo Y; Fornage M; Hayward C; Mathias RA; Kilpeläinen TO; Lange LA; Cox SR; März W; Morange PE; Rotter JI; Mook-Kanamori DO; Wilson JF; van der Harst P; Jukema JW; Ikram MA; Blangero J; Kooperberg C; Desch KC; Johnson AD; Sabater-Lleal M; Lowenstein CJ; Smith NL; Morrison AC
    Blood; 2024 May; 143(18):1845-1855. PubMed ID: 38320121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium.
    Smith NL; Chen MH; Dehghan A; Strachan DP; Basu S; Soranzo N; Hayward C; Rudan I; Sabater-Lleal M; Bis JC; de Maat MP; Rumley A; Kong X; Yang Q; Williams FM; Vitart V; Campbell H; Mälarstig A; Wiggins KL; Van Duijn CM; McArdle WL; Pankow JS; Johnson AD; Silveira A; McKnight B; Uitterlinden AG; ; Aleksic N; Meigs JB; Peters A; Koenig W; Cushman M; Kathiresan S; Rotter JI; Bovill EG; Hofman A; Boerwinkle E; Tofler GH; Peden JF; Psaty BM; Leebeek F; Folsom AR; Larson MG; Spector TD; Wright AF; Wilson JF; Hamsten A; Lumley T; Witteman JC; Tang W; O'Donnell CJ
    Circulation; 2010 Mar; 121(12):1382-92. PubMed ID: 20231535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact on venous thrombosis risk of newly discovered gene variants associated with FVIII and VWF plasma levels.
    Morange PE; Saut N; Antoni G; Emmerich J; Trégouët DA
    J Thromb Haemost; 2011 Jan; 9(1):229-31. PubMed ID: 21029358
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined analysis of three genome-wide association studies on vWF and FVIII plasma levels.
    Antoni G; Oudot-Mellakh T; Dimitromanolakis A; Germain M; Cohen W; Wells P; Lathrop M; Gagnon F; Morange PE; Tregouet DA
    BMC Med Genet; 2011 Aug; 12():102. PubMed ID: 21810271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In patients with deep-vein thrombosis elevated levels of factor VIII correlate only with von Willebrand factor but not other endothelial cell-derived coagulation and fibrinolysis proteins.
    Bombeli T; Jutzi M; De Conno E; Seifert B; Fehr J
    Blood Coagul Fibrinolysis; 2002 Oct; 13(7):577-81. PubMed ID: 12439142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Thyroid Function on Hemostasis, Coagulation, and Fibrinolysis: A Mendelian Randomization Study.
    Ellervik C; Mora S; Kuś A; Åsvold B; Marouli E; Deloukas P; Sterenborg RBTM; Teumer A; Burgess S; Sabater-Lleal M; Huffman J; Johnson AD; Trégouet DA; Smith NL; Medici M; DeVries PS; Chasman DI; Kjaergaard AD
    Thyroid; 2021 Sep; 31(9):1305-1315. PubMed ID: 34210154
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic regulation of plasma von Willebrand factor levels in health and disease.
    Swystun LL; Lillicrap D
    J Thromb Haemost; 2018 Dec; 16(12):2375-2390. PubMed ID: 30246494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral venous thrombosis and plasma concentrations of factor VIII and von Willebrand factor: a case control study.
    Bugnicourt JM; Roussel B; Tramier B; Lamy C; Godefroy O
    J Neurol Neurosurg Psychiatry; 2007 Jul; 78(7):699-701. PubMed ID: 17189302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mendelian Randomization Analysis of Hemostatic Factors and Their Contribution to Peripheral Artery Disease-Brief Report.
    Small AM; Huffman JE; Klarin D; Sabater-Lleal M; Lynch JA; Assimes TL; Sun YV; Miller D; Freiberg MS; Morrison AC; Rader DJ; Wilson PWF; Cho K; Tsao PS; Chang KM; Smith NL; O'Donnell CJ; de Vries PS; Damrauer SM;
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):380-386. PubMed ID: 32847391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of the sinusoidal endothelial cell receptors CLEC4M, stabilin-2, and SCARA5 to VWF-FVIII clearance in thrombosis and hemostasis.
    Swystun LL; Michels A; Lillicrap D
    J Thromb Haemost; 2023 Aug; 21(8):2007-2019. PubMed ID: 37085036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coagulation biomarkers are independent predictors of increased oxygen requirements in COVID-19.
    Rauch A; Labreuche J; Lassalle F; Goutay J; Caplan M; Charbonnier L; Rohn A; Jeanpierre E; Dupont A; Duhamel A; Faure K; Lambert M; Kipnis E; Garrigue D; Lenting PJ; Poissy J; Susen S
    J Thromb Haemost; 2020 Nov; 18(11):2942-2953. PubMed ID: 32881304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals.
    Schleef M; Strobel E; Dick A; Frank J; Schramm W; Spannagl M
    Br J Haematol; 2005 Jan; 128(1):100-7. PubMed ID: 15606555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term increased factor VIII levels are associated to interleukin-6 levels but not to post-thrombotic syndrome in patients with deep venous thrombosis.
    Bittar LF; Mazetto Bde M; Orsi FL; Collela MP; De Paula EV; Annichino-Bizzacchi JM
    Thromb Res; 2015 Mar; 135(3):497-501. PubMed ID: 25575413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rise of levels of von Willebrand factor and factor VIII with age: Role of genetic and acquired risk factors.
    Biguzzi E; Castelli F; Lijfering WM; Cannegieter SC; Eikenboom J; Rosendaal FR; van Hylckama Vlieg A
    Thromb Res; 2021 Jan; 197():172-178. PubMed ID: 33221577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene-centric approach identifies new and known loci for FVIII activity and VWF antigen levels in European Americans and African Americans.
    Tang W; Cushman M; Green D; Rich SS; Lange LA; Yang Q; Tracy RP; Tofler GH; Basu S; Wilson JG; Keating BJ; Weng LC; Taylor HA; Jacobs DR; Delaney JA; Palmer CD; Young T; Pankow JS; O'Donnell CJ; Smith NL; Reiner AP; Folsom AR
    Am J Hematol; 2015 Jun; 90(6):534-40. PubMed ID: 25779970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between von Willebrand factor antigen, von Willebrand factor ristocetin cofactor activity and factor VIII activity in plasma.
    Lippi G; Franchini M; Salvagno GL; Montagnana M; Poli G; Guidi GC
    J Thromb Thrombolysis; 2008 Oct; 26(2):150-3. PubMed ID: 17786534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. von Willebrand factor and factor VIII as risk factors for arterial and venous thrombosis.
    Martinelli I
    Semin Hematol; 2005 Jan; 42(1):49-55. PubMed ID: 15662616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coagulation factor VIII: Relationship to cardiovascular disease risk and whole genome sequence and epigenome-wide analysis in African Americans.
    Raffield LM; Lu AT; Szeto MD; Little A; Grinde KE; Shaw J; Auer PL; Cushman M; Horvath S; Irvin MR; Lange EM; Lange LA; Nickerson DA; Thornton TA; Wilson JG; Wheeler MM; ; Zakai NA; Reiner AP
    J Thromb Haemost; 2020 Jun; 18(6):1335-1347. PubMed ID: 31985870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.